Survey on the Pharmacy Follow-up of Alli Purchasers

To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.

Completed

Looking for future studies?

Key information

Conditions

Overweight Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Overnutrition Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.

Treatment and study plan

Orlistat

Drug

60 mg

Primary outcomes

Change in Physical activity

Time frame: baseline to 1 year

Secondary outcomes

Change in dietary behavior

Time frame: baseline to 1 year
Evaluation of care pathway (e.g., consultation with doctors, use of nutritional information)

Time frame: baseline to 1 year
Satisfaction with management (i.e., results on weight and treatment comfort)

Time frame: baseline to 1 year

Sponsors and collaborators

Lead sponsor

GlaxoSmithKline

Industry

Registry information

Official study title

Survey on the Pharmacy Follow up of Alli Purchasers

Important dates

Study start: 2010
Primary completion: 2010
Study completion: 2010
First posted: Jul 4, 2011
Registry last updated: Oct 29, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed